Alzeca Biosciences alzeca.com

Alzeca Biosciences develops imaging compounds to diagnose Alzheimer's disease at the earliest stages. Early detection of Alzheimer's is critical as disease pathology begins to accumulate 10+ years prior to cognitive onset of the disease. As a result, early detection of Alzheimer's pathology offers the patient an opportunity to take counteractive measures at a point where the disease may still be treatable.

Alzeca Biosciences develops imaging compounds to diagnose Alzheimer's disease at the earliest stages. Early detection of Alzheimer's is critical as disease pathology begins to accumulate 10+ years prior to cognitive onset of the disease. As a result,...Show all

Company (Alive / Active)

All investors data 3 Investors

• Central Texas Angel Network
• Chemwerth
• Nevakar